600812 华北制药
2025/09 - 九个月
人民币(K¥)
与去年末期
比较
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)

非流动资产
长期股权投资1,228,6423.50%1,187,0391,202,161900,516858,439
投资性房地产0--0000
固定资产6,256,511-0.67%6,298,7106,446,8316,786,0656,727,235
在建工程378,117-0.79%381,137162,347154,672672,475
无形资产2,846,8443.30%2,755,9971,974,8211,650,3321,344,494
商誉0--03,3373,3373,337
其他非流动资产2,490,550-3.81%2,589,2953,149,6122,743,1982,611,759
13,200,665-0.09%13,212,17812,939,10912,238,11912,217,739

流动资产
货币资金1,605,062-3.33%1,660,279988,2761,682,7375,304,983
应收账款2,422,54018.21%2,049,3771,930,9032,231,0661,958,743
存货2,253,266-10.25%2,510,5352,607,7842,523,3012,391,909
其他流动资产2,055,7520.82%2,039,0902,490,6282,545,7943,056,561
8,336,6200.94%8,259,2808,017,5918,982,89912,712,196

流动负债
短期借款6,619,708-6.70%7,094,9955,467,7105,276,0647,626,525
应付票据391,108-13.32%451,197581,040829,406766,489
应付帐款1,807,760-1.96%1,843,8801,908,8551,953,2272,124,659
其他流动负债3,591,098128.52%1,571,4572,310,9604,350,5223,722,222
12,409,67313.21%10,961,53010,268,56512,409,21914,239,895
流动资产净值(4,073,053)50.73%(2,702,250)(2,250,974)(3,426,320)(1,527,699)
资产总额减流动负债9,127,612-13.15%10,509,92810,688,1358,811,79910,690,040

非流动负债
长期借款2,181,118-36.94%3,458,9214,080,8582,129,0703,300,735
应付债券0--0000
其他非流动负债272,465-27.61%376,395336,866454,353372,074
2,453,583-36.03%3,835,3154,417,7252,583,4233,672,809

总权益
    实收股本1,715,7300.00%1,715,7301,715,7301,715,7301,715,730
    储备项目3,789,4953.15%3,673,6733,599,5733,584,3954,369,751
股东权益5,505,2252.15%5,389,4035,315,3045,300,1256,085,481
非控股权益1,168,804-9.06%1,285,210955,107928,251931,750